BioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials
recent articles
Two of Moderna’s founders, and one investor, are among 44 new billionaires on the Forbes 400 list this year At least three people with a stake in the coronavirus vaccine race have just made a list of the top 400 richest people in...
Top 5 Reasons WHY YOU SHOULD ADOPT DIGITAL PATHOLOGY INTO YOUR LABORATORY Thinking about going digital in your lab? Download this informative article that can help answer some of the most frequently asked questions about adopting digital...
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization...
Findings of multi-site study highlight potential of technology in real-world practice PHILADELPHIA – October 5, 2021 – Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new...
AIRA Matrix CEO, Chaith Kondragunta will be speaking at Intelligent Health 2021 on the application of Deep Learning applications that speed up the preclinical phase of drug discovery and development. The Tech Talk titled “Using Deep...
A preview of arguments to come After a tedious day of bickering, Victoria Sung appeared like manna from heaven — to tell us that Theranos’ tests sucked. Sung worked at Celgene when it contracted with Theranos. Her testimony was brief and...
